2026 NPPES data Medical Oncology Physician NPI 1437313491 M.D., PH.D., FACP
Verify on CMS →

BORIS NARAEV, M.D., PH.D., FACP

Medical Oncology Physician in TAMPA, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
295
Medicare Part D claims · 78 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$23.6K
48 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BORIS NARAEV, M.D., PH.D., FACP filed 295 Medicare Part D claims in 2023 as a Medical Oncology Physician in TAMPA, Florida, prescribing 91% generic.

295
Part D claims, 2023
91%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BORIS NARAEV, M.D., PH.D., FACP's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

295 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

BORIS NARAEV, M.D., PH.D., FACP practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BORIS NARAEV, M.D., PH.D., FACP?

Quality data not reported

NPI registry status

Active

Issued 07/17/2008

NPI 1437313491

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

295 57% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Florida

How Medical Oncology Physician compares to other specialties among Florida providers

Florida providers

Medical Oncology Physician share within Florida

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BORIS NARAEV, M.D., PH.D., FACP appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D., PH.D., FACP credentials at 10740 PALM RIVER RD STE 360, TAMPA, FL, 33619, with a listed phone of (813) 844-7585. NPI 1437313491 was issued on 07/17/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what NARAEV most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 295 prescription claims written by this provider, covering 78 Medicare beneficiaries and totaling roughly $74K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 6.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10740 PALM RIVER RD STE 360
TAMPA, FL 33619

Provider Details

NPI 1437313491
Specialty Medical Oncology Physician
Credentials M.D., PH.D., FACP
Gender Male
NPI Issued 07/17/2008

Hospital and facility affiliations

Facilities where BORIS NARAEV, M.D., PH.D., FACP bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

TAMPA GENERAL MEDICAL GROUP INC
TAMPA, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BORIS NARAEV, M.D., PH.D., FACP. Source: openpaymentsdata.cms.gov.

Total received

$23.6K

Largest payer

Exelixis Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to BORIS NARAEV, M.D., PH.D., FACP. To verify BORIS NARAEV, M.D., PH.D., FACP's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

BORIS NARAEV, M.D., PH.D., FACP — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 295 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

295
Total Claims
$74K
Total Drug Cost
78
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
307
Total Day Supply
4,930
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$68K
Generic Drug Cost
$6K
Opioid Claims
18 (6.1% rate)

Patient Demographics

Average Patient Age
74.6 years
Avg HCC Risk Score
2.26
Gender Split
38% female / 62% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BORIS NARAEV, M.D., PH.D., FACP prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prochlorperazine Maleate
68
Ondansetron Odt
Ondansetron
46
Diphenoxylate-Atropine
Diphenoxylate Hcl/Atropine
26
Lidocaine-Prilocaine
Lidocaine/Prilocaine
22
Creon
Lipase/Protease/Amylase
19
Ondansetron Hcl
15
Potassium Chloride
13
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How BORIS NARAEV, M.D., PH.D., FACP fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

BORIS NARAEV, M.D., PH.D., FACP's 295 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as NARAEV.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BORIS NARAEV, M.D., PH.D., FACP's specialty?
BORIS NARAEV, M.D., PH.D., FACP specializes in Medical Oncology Physician and practices in TAMPA, Florida. Credentials: M.D., PH.D., FACP.
How much does BORIS NARAEV, M.D., PH.D., FACP prescribe under Medicare Part D?
In 2023, BORIS NARAEV, M.D., PH.D., FACP wrote 295 Medicare Part D claims totaling $74K in drug costs for 78 beneficiaries.
Where is BORIS NARAEV, M.D., PH.D., FACP located?
BORIS NARAEV, M.D., PH.D., FACP is located at 10740 PALM RIVER RD STE 360, TAMPA, FL, 33619. Phone: (813) 844-7585.
What is BORIS NARAEV, M.D., PH.D., FACP's NPI number?
BORIS NARAEV, M.D., PH.D., FACP's National Provider Identifier (NPI) is 1437313491, issued on 07/17/2008.
Does BORIS NARAEV, M.D., PH.D., FACP prescribe more brand-name or generic drugs?
BORIS NARAEV, M.D., PH.D., FACP's prescribing is 9% brand-name and 91% generic drugs by claim count, with $68K in brand drug costs.
Does BORIS NARAEV, M.D., PH.D., FACP prescribe opioids?
Yes, BORIS NARAEV, M.D., PH.D., FACP had 18 opioid claims in 2023 with an opioid prescribing rate of 6.1%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does BORIS NARAEV, M.D., PH.D., FACP prescribe most often?
Based on 2023 Medicare Part D data, BORIS NARAEV, M.D., PH.D., FACP's most frequently prescribed drugs include Prochlorperazine Maleate, Ondansetron Odt, Diphenoxylate-Atropine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BORIS NARAEV, M.D., PH.D., FACP accept Medicare?
BORIS NARAEV, M.D., PH.D., FACP appears in CMS Medicare data with 295 Part D claims and 78 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BORIS NARAEV, M.D., PH.D., FACP's credentials?
BORIS NARAEV, M.D., PH.D., FACP's NPI is 1437313491 with credentials M.D., PH.D., FACP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology